SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-17-031595
Filing Date
2017-05-10
Accepted
2017-05-10 16:38:55
Documents
66
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a17-8919_110q.htm 10-Q 1069577
2 EX-31.1 a17-8919_1ex31d1.htm EX-31.1 11859
3 EX-31.2 a17-8919_1ex31d2.htm EX-31.2 12020
4 EX-32.1 a17-8919_1ex32d1.htm EX-32.1 5867
5 EX-32.2 a17-8919_1ex32d2.htm EX-32.2 5872
  Complete submission text file 0001104659-17-031595.txt   5215358

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT stml-20170331.xml EX-101.INS 1250576
7 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT stml-20170331.xsd EX-101.SCH 42961
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT stml-20170331_cal.xml EX-101.CAL 42431
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT stml-20170331_def.xml EX-101.DEF 134426
10 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT stml-20170331_lab.xml EX-101.LAB 389399
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT stml-20170331_pre.xml EX-101.PRE 265475
Mailing Address 750 LEXINGTON AVENUE NEW YORK NY 10022
Business Address 750 LEXINGTON AVENUE ELEVENTH FLOOR NEW YORK NY 10022 646-502-2311
STEMLINE THERAPEUTICS INC (Filer) CIK: 0001264587 (see all company filings)

IRS No.: 450522567 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35619 | Film No.: 17831007
SIC: 2834 Pharmaceutical Preparations